ASAH3 Activators

ASAH3 can enhance its enzymatic function through various biochemical interactions. Sphingosine acts as a ligand for sphingosine-1-phosphate (S1P) receptors, which in turn can lead to the activation of ASAH3, due to its role in converting ceramide to sphingosine in sphingolipid metabolism. Similarly, C2-Ceramide, which serves as a ceramide mimic, can be hydrolyzed by ASAH3 to produce sphingosine, thus directly providing the substrate for the enzyme's action and potentially increasing its activity. Sphingomyelin is another substrate that upon breakdown yields ceramide, which can then be hydrolyzed by ASAH3, suggesting that increased turnover of sphingomyelin can indirectly result in heightened activity of ASAH3. Phytosphingosine, a sphingoid base, also undergoes deacetylation by ASAH3, and this interaction is likely to increase the enzyme's activity by engaging it with its substrate.

Fingolimod, after being phosphorylated in vivo, forms an S1P analog that can activate S1P receptors, which might lead to enhanced activity of ASAH3 through a feedback mechanism in the sphingolipid metabolism pathway. Ceranib-2, though a ceramidase inhibitor, may increase ASAH3 activity by causing an accumulation of ceramide, thus potentially leading to feedback activation of ASAH3 to manage ceramide levels. Safingol, a synthetic sphinganine analog, can be metabolized by sphingolipid enzymes, which includes ASAH3, suggesting that its presence can lead to increased activity of ASAH3. PDMP, by inhibiting glucosylceramide synthase, can cause a buildup of ceramide, providing more substrate for ASAH3 and potentially enhancing its activity. β-Glucosylceramide, which can be converted back to ceramide, may also indirectly enhance ASAH3 activity by increasing the pool of ceramide. Additionally, D-erythro-Sphingosine and N-stearoyl-sphinganine are substrates that ASAH3 can act upon, with the enzyme's activity increasing as it processes these molecules to yield sphingosine and free fatty acids, respectively.